Open AccessTyrosine kinase inhibitors in breast cancer (Review)
Author(s) -
George Iancu,
Dragoş Şerban,
Cristinel Badiu,
Ciprian Tănăsescu,
Mihai Tudosie,
Corneliu Tudor,
Daniel Ovidiu Costea,
Anca Zgură,
Raluca Iancu,
Danut Vasile
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.11037
Subject(s) - lapatinib , trastuzumab , neratinib , medicine , breast cancer , pertuzumab , monoclonal antibody , tyrosine kinase , sunitinib , cancer , targeted therapy , oncology , cardiotoxicity , adverse effect , cancer research , pharmacology , immunology , antibody , chemotherapy , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom